Drug Type Small molecule drug |
Synonyms Lipoic ester (-)-15( Soochow University ) |
Mechanism 5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists), D2 receptor agonists(Dopamine D2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H33NO2S2 |
InChIKeyJCKSBFDVTFRZJP-JFGZAKSSSA-N |
CAS Registry1206536-27-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | CN | 14 Jul 2011 |